课题基金 / 基金详情

项目摘要

项目成果

DORIT HANEIN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):程序性细胞死亡在人类健康和疾病中起着关键作用。细胞生存和死亡的信号由bcl2家族蛋白调节,并汇聚在线粒体,在那里最终决定细胞的命运。BCL-2蛋白活性对维持线粒体和细胞生理学至关重要,也与人类主要疾病,特别是癌症有关。因此,了解它们的作用机制具有很高的生物医学优先级。Bcl2家族包括亲生命蛋白(如bclxl)和促死亡蛋白(如bax),当它们在细胞质和线粒体外膜之间转移时,通过分子间相互作用网络发挥其调节功能。线粒体膜结合是细胞程序性死亡的关键早期步骤,然而,膜结合介导bcl2蛋白功能的确切机制尚不清楚。本项目重点回答了核心问题:bcl-xl、bax和Bid这三个关键的bcl2相关基因如何在可溶状态和膜插入状态之间转换,发挥其促凋亡和抗凋亡活性?
英文摘要
DESCRIPTION (provided by applicant): Programmed cell death plays key roles in human health and disease. Signals for cellular life and death are regulated by the BCL-2 family proteins and converge at the mitochondria, where cell fate is ultimately decided. BCL-2 protein activities are critical for maintaining mitochondrial and cellular physiology, and are also linked with major human diseases, especially cancer. Thus, understanding their mechanisms of action has high biomedical priority. The BCL-2 family includes both pro-life (e.g. BCL-XL) and pro-death (e.g. BAX) proteins that exert their regulatory functions through a network of intermolecular interactions as they translocate between the cytoplasm and the mitochondrial outer membrane. Mitochondrial membrane association is a key early step of programmed cell death; however, the exact mechanism through which membrane association mediates BCL-2 protein function is not known. This project focuses on answering the central question: how do the three key BCL-2 relatives, BCL-XL, BAX and BID, transition between soluble and membrane-inserted states to exert their pro- and anti-apoptotic activities?
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cryo Transmission Electron Microscope for SPA, Cryo-ET and MicroED studies at UCSB
Structure and function of the Plasmodium myosin XIV-actin glideosome
Structure and function of the Plasmodium myosin XIV-actin glideosome
International Conference on Image Analysis in Three-dimensional Cryo-EM
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: